A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

Predicting who will transition from acute to chronic pain is the “holy grail” of pain neuroscience. A novel biomarker ...

In an international effort, researchers at Western, the University of Maryland School of Dentistry (UMSOD) and Neuroscience ...

Having lived with disabling chronic pain for 32 years, one reader discovered a lesser known treatment that has transformed ...

A novel biomarker signature combining PAF and CME predicts chronic pain risk, linking brain activity to individual pain ...

Like a typical teenager, Abby Weiss guts through her nightly homework. But she also is gutting through the near-constant pain ...

Researchers have uncovered how specific patterns in brain activity can predict an individual's sensitivity to pain, expanding opportunities for improved pain management strategies.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

These biomarkers help clinicians diagnose, prevent, and treat patients with chronic pain. Scientists experience multiple challenges in determining pain biomarkers, potentially associated with ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...